# Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.

> **NCT07556562** · NA · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 260 (estimated)

## Conditions studied

- Germline Mutations

## Interventions

- **PROCEDURE:** RRSO (risk-reducing salpingo- oophorectomy) or RRS (risk-reducing salpingectomy)

## Key facts

- **NCT ID:** NCT07556562
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-09
- **Primary completion:** 2026-08-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07556562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07556562, "Early Diagnosis of High-grade Serous Epithelial Ovarian Cancer Through the Analysis of DNA Derived From Pap Test Smear.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07556562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*